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The physical and engineering sciences have much to offer in understanding,
diagnosing, and even treating cancer. Microfluidics, imaging, materials, and diverse
measurement devices are all helping to shift paradigms of tumorigenesis and
dissemination. Using materials and micro-probes of elasticity, for example, epithelia
have been shown to transform into mesenchymal cells when the elasticity of adjacent
tissue increases. Approaches common in engineering science enable such discoveries,
and further application of such tools and principles will likely improve existing cancer
models in vivo and also create better models for high throughput analyses in vitro. As
profiled in this special topic issue composed of more than a dozen manuscripts,
opportunities abound for the creativity and analytics of engineering and the physi-
cal sciences to make advances in and against cancer. VC 2018 Author(s). All article
content, except where otherwise noted, is licensed under a Creative Commons
Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
https://doi.org/10.1063/1.5056176
INTRODUCTION
The complex, heterogeneous structures of tumors and their propensity to invade other tis-
sues of the body have significantly slowed the potential progress toward understanding cancer
and its origins and treatments. Engineering approaches, on the other hand, take inherently com-
plex systems and reduce them to their constituent parts, properties, and processes. A tumor
could include not only cells within the tumor but also the surrounding extracellular matrix
(ECM) that anchors the tumor, stromal fibroblasts that secrete proteins for and support the
tumor, and the various fluids that flow into and out of the tumor. Each aspect requires a careful
study, and the manuscripts published in this special issue are testament to that general
approach. They deepen understanding by advanced imaging or by building simple systems to
focus on a microenvironment property, such as ECM that is stiffer,1 more dense,2 crosslinked,3
aligned,1 or less porous.3 The efforts profiled here investigate or summarize our knowledge of
tumors in four ways: (1) some clarify how intratumor or stromal fluid4,5 or blood flow6 drives
tumor behavior, (2) others develop model in vitro systems to understand7–10 or measure11 tumor
behavior, (3) still others examine how cancer cells sense changes in their niche12 and how that
drive behaviors,13,14 and (4) a few are more integrative with computational simulations of com-
plex processes in cancer.15–17
FLUID FLUX WITHIN AND AROUND TUMORS
Because we are about 70% water, our tissues are constantly transporting fluids—and not
just blood. Almost two decades ago, engineers were beginning to create complex mathematical
models of such flows in tumors18 but not until recently have non-invasive imaging methods
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been able to observe these flows in vivo. Kingsmore and co-workers4 used dynamic contrast-
enhanced magnetic resonance imaging (MRI) and a training model to validate in situ that their
dynamic contrast enhancement and analytical processing could yield accurate velocity vectors
within a glioblastoma multiforme (GBM) xenograft model. Heterogeneous fluid flows within
and around tumors suggest further refinements for mathematical models and correlations with
drug treatment.19 Similar dynamics with solid shear stress, among other mechanical inputs,
could also affect solid tumors. Mehta and co-workers5 summarized how both fluid shear, in par-
ticular ascites flow, through the ovary and solid shear from relative movements within the body
could impact tumor behavior. Mehta et al. surmised that bioreactors and other fluid shear devi-
ces can greatly improve our understanding of such forces, thus highlighting how engineering
sciences might illuminate some aspects of complex cancer processes.
CANCER-IN-A-DISH
Reducing a system’s complexity through engineering methods can help advance cancer biol-
ogy in terms of mechanistic understanding or perhaps with a goal of exploiting a cell’s properties
as a means of separation. Both approaches are highlighted in this special issue. For example, it
can be difficult in normally complex tumors to identify how clinically relevant doses of radiation
affect cells and their matrix,20 but as Reinhart-King and coworkers showed, ionizing radiation
reduces collagen matrix stiffness without concomitant changes to matrix porosity or architecture.
Non-irradiated cancer cells then show reduced adhesion, spreading, and migration when plated
onto the irradiated matrix, suggesting that stiffness changes may affect tissue mechanics. Cell
arrangement can also be a key feature of a reductionist system. Mammary epithelial cells form
sheets in 2D and hollow acinar structures in 3D; their mechano-sensing is also dramatically
altered between these states1,21 as cell-ECM and cell-cell cues balance each other. Tanner10
highlighted how hydrogels and other systems can be modified to probe mechanobiological
questions in the brain. Kumar and coworkers9 further demonstrated this principal for GBM by
fabricating a 3D hyaluronic acid (HA) hydrogel system with channels to embed cells and mimic
vasculature. They observed invasion of the parenchymal-like HA or collagen I hydrogel and sub-
sequent penetration of the vascular mimic, whereby cells migrate faster on collagen. Similarly,
Fleszar and coworkers7 probed the effects of the matrix composition on fallopian tube epithelium
in a 3D system with a built-in lumen. As with Kumar and coworkers, Fleszar found that specific
collagen types along with the presence of fluid shear influence epithelium behavior, including
migration and invasion into surrounding stroma which is relevant to cortical inclusion cysts in
ovarian cancers. Engineering approaches can thus create devices in which to test reductionist
hypotheses that would be exceedingly difficult to evaluate in a controlled manner in vivo.
The bioengineering alternative to studying cell behaviors in a reductionist environment is
to exploit a cell’s properties as a means of separation. Over the past decade, systems have been
developed to separate cancer cells from solid tissues and blood. While most associate cancer
with solid tumors, cancer cells must hijack the vasculature to spread to distant tissues,22 and
this has provided a convenient entry point for many separation methods; engineers have used
fluidics to centrifuge larger cancer cells from buffers and blood.23 Fluidics and optics together
allow the user to stretch24,25 or squeeze cells,26 determine their deformability, and then make
sorting decisions; cancer cells generally are softer than their surrounding counterparts, and use
of this principle to sort cancer cells is sometimes referred to as deformation cytometry (DC).
Recent efforts have included enhanced throughput to make real-time DC27 and as highlighted
here by Ahmmed and coworkers,11 multiplexed sorting can decrease the sorting times by
increasing the channel number on the chip. While some of the above systems are sufficiently
large to prevent clogging, a multiplexed sorting chip can help ensure a continuous sort process.
I’VE GOTA FEELIN’: SENSING AND RESPONSE IN CANCER
A third area that bioengineering research has “metastasized” to is understanding to what
extent and why cells respond to the cues in in vitro systems. Subfields of mechanobiology and
mechanotransduction often address these questions, and three examples of such work in this
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special issue highlight distinct signaling mechanisms. First, it is important to establish if a cell
behavior in an engineered system is guided by single or multicellular responses; such is the
focus of the work by Gligorijevic and co-workers14 where the balance between contact guid-
ance and chemotactic cues was examined together with the cell cycle and proliferation. Cells
might “decide” to migrate singly through constrictions, even going so far as to rupture their
nuclei.28,29 Heureaux-Torres and coworkers12 presented data in this issue, suggesting that
signaling from the mechanosensitive channel of large conductance (MscL) may serve as a
“go”-“no go” switch; MscL expressing cancer cells migrated at the same velocity as their non-
expressing counterparts, but Heureaux-Torres observed that MscL cells more frequently get
“stuck” at the entrance of constricting channels. They fail to crawl into a channel at higher
rates, perhaps sensing that the constriction is too excessive. In migrating through tumor stroma,
cancer cells have been observed to fuse with stromal cells, and Chitwood and coworkers13 dis-
covered that hybrid cells form spontaneously and at a significantly higher rate in metastases.
This could add genetic diversity and also provide transcripts and proteins from primary stroma
to condition the distant niche at a metastatic site. In all of these examples, it is critical to note
that engineered systems, whether a reductionist in vitro mimic or a specific reporter probe engi-
neered to fluoresce under specific conditions, were critical in identifying these mechanisms.
COMPUTING COMPLEXITY, INCLUDING MUTATIONS
As cells migrate and find new niches, they must integrate a plethora of signals along their
path. Reductionist approaches in this instance can often oversimplify the system and miss impor-
tant emergent behaviors. In silico approaches using computational modeling can take individual
parameters known to be influential and test them in a large combinatorial matrix to establish, for
example, that in 2D, stiffness, ligand density, and ligand composition affect metastatic cancer cell
migration, but in 3D, tight pores necessitate migration mediated by matrix degradation.30 While
migration is often examined individually, cancer cells can also exhibit coordinated migration.31 In
this issue, Sun and coworkers16 developed a collective migration model for confluent epithelia
based on vertex modeling, i.e., where cancer cells are treated as polygons with shared vertices
and edges. Cells within the layer experience passive, frictional, and contractile forces from
cell-cell and cell-ECM contacts, and when arranged as a sheet, individual cancer cells undergo
periodic migration during continuous migration of the sheet or streaming behavior, i.e., rotation
of the sheet. Differences in this behavior occur as a function of density, contractility, and persis-
tence. Along with migration, epithelia make equally complex decisions to undergo epithelial-
to-mesenchymal transition (EMT) or not; numerous overlapping transcription factors govern
expression of the genes that control this process, and these factors are activated by a number of
external cues.32–34 Also in this issue, Jolly and coworkers15 examined the pathways that lead to
EMT, identifying a series of feedback loops that enable epithelial cells to maintain a stable, hybrid
phenotype with both epithelial and mesenchymal characteristics. Their model also indicates
ESRP1 as a crucial signaling node that when knocked down in a cancer line leads from this stable
hybrid state into EMT; in patients, it correlates with poor prognosis.
Cancer only arises from mutations, and computational approaches can also usefully mine
big data that are rapidly accumulating from whole-genome sequencing (WGS). The consider-
able engineering advances that profoundly reduced the costs of sequencing are now producing
tera-bytes of such data for an increasing number of patients—as was the vision of physicists
and engineers in the Department of Energy who first conceived of the Human Genome Project
decades ago in order to sequence DNA for radiation-induced mutations.35 In this issue, Alter
and coworkers17 analyzed patient-matched astrocytomas and non-malignant tissues using gener-
alized singular value decomposition and uncovered patterns in genes within Notch, Ras, and
Shh pathways. Compared to age or tumor grade, the patterns provide more accurate predictors
of recurrence free survival and response to chemotherapy and radiation therapy.
In summary, this special issue provides an opportunity for readers to experience all the
ways that bioengineering can be applied to cancer: to precisely measure individual components
of a system to take an inherently complex system and reduce it to constituent parts to examine
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key features or to model complexity. While conventional biological approaches have brought
tremendous advances to cancer diagnostics and treatments over the last century, it is the oppor-
tunity that engineering analysis affords as highlighted here that may very well propel us into
the next century of cancer breakthroughs.
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